Pegasus Pharmaceuticals Inc. Invited to Present at Parenteral Drug Association Fungal Contamination Control Conferences
2/5/2013 10:12:04 AM
More...
|
Pegasus Pharmaceuticals Inc. Release: Clinical Studies Completed for HeartVue's 6S Heart Screening System
8/18/2008 9:39:44 AM
More...
|
Pegasus Pharmaceuticals Inc. Files Patents on New Biological Toxic Mold Control Product, Opens Lab & Appoints Distributor for Marketing to Multi-Billion Dollar Worldwide Mold Removal Market
3/28/2008 9:13:13 AM
More...
|
Pegasus Pharmaceuticals Inc. Acquires Worldwide Marketing Rights To Effective Biological-Concept Mold Remove System -- Laboratory Tests Successfully Completed
1/8/2007 11:03:04 AM
More...
|
Pegasus Pharmaceuticals Inc. And HeartView To Market Its HeartVue 6S Screening Device In Europe
10/30/2006 11:59:37 AM
More...
|
Pegasus Pharmaceuticals Inc. And HeartView Delivers First Shipment Of 55 HeartVue 6S System Electrocardiograph Units To China
6/27/2006 12:08:39 PM
More...
|
Pegasus Pharmaceuticals Inc.' HeartVue 6S System Successfully Demonstrated To Cardiologists At American College of Cardiology 55th Scientific Session Exposition In Atlanta
4/11/2006 12:10:40 PM
More...
|
Pegasus Pharmaceuticals Inc./Heartview Signs Multi-Year Sales Agreement For China For Ground-Breaking HeartVue(TM) 6C System Technology
2/9/2006 3:12:27 PM
More...
|
Pegasus Biologics, Inc. To Present At Medtech Insight's "Investment in Innovation" Conference
10/19/2005 5:12:36 PM
More...
|
Pegasus Pharmaceuticals Inc. Signs Agreement With Heartview
10/19/2005 5:12:31 PM
More...
|